drugs glp-1 What to Make of the Coverage and Cost Landscape Could GLP-1 Drugs Lower Epilepsy

For commercial plans in the US, there will be an increasing pressure to follow Medicares lead and cover obesity more broadly, which will require careful evaluation of budget impact in the short- and long-term

Gallstone disease was also linked with the long-term use of GLP-1 agonist drugs

Even then, prescribing didnt really pick up until after 2022 when the FDA approved a weekly GLP-1 injection medication

Brain Journal

Healthcare professionals can choose between GLP-1 RAs and SGLT2Is in T2D patients with high CV risks

doi: 10.2174/1871529X18666180206130218 30 ImprialosKFaselisCBoutariCStavropoulosKAthyrosVKaragiannisAet al